Chandrasekhar Yallampalli

Prof. Dr. Chandrasekhar Yallampalli


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Placenta
Verified
Journal Article
Closed access
KGKetan B. Ghaghada
Ketan B. Ghaghada
ZSZbigniew A. Starosolski
Zbigniew A. Starosolski
SBSaakshi Bhayana
Saakshi Bhayana
ISIgor Stupin
Igor Stupin
CPChandreshkumar V. Patel
Chandreshkumar V. Patel
AAAnanth V. Annapragada
Ananth V. Annapragada

11 March 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MPMary C. Peavey
Mary C. Peavey
SWSan-Pin Wu
San-Pin Wu
RLRong Li
Rong Li
JLJian Liu
Jian Liu
OEOlivia M. Emery
Olivia M. Emery
FDFrancesco John DeMayo
Francesco John DeMayo
Uterine contractile dysfunction leads to pregnancy complications such as preterm birth and labor dystocia. In humans, it is hypothesized that progesterone receptor isoform PGR-B promotes a relaxed state of the myometrium, and PGR-A facilitates uterine contraction. This hypothesis was tested in vivo using transgenic mouse models that overexpress PGR-A or PGR-B in smooth muscle cells. Elevated PGR-B abundance results in a marked increase in gestational length compared to control mice (21.1 versus 19.1 d respectively, P < 0.05). In both ex vivo and in vivo experiments, PGR-B overexpression leads to prolonged labor, a significant decrease in uterine contractility, and a high incidence of labor dystocia. Conversely, PGR-A overexpression leads to an increase in uterine contractility without a change in gestational length. Uterine RNA sequencing at midpregnancy identified 1,174 isoform-specific downstream targets and 424 genes that are commonly regulated by both PGR isoforms. Gene signature analyses further reveal PGR-B for muscle relaxation and PGR-A being proinflammatory. Elevated PGR-B abundance reduces Oxtr and Trpc3 and increases Plcl2 expression, which manifests a genetic profile of compromised oxytocin signaling. Functionally, both endogenous PLCL2 and its paralog PLCL1 can attenuate uterine muscle cell contraction in a CRISPRa-based assay system. These findings provide in vivo support that PGR isoform levels determine distinct transcriptomic landscapes and pathways in myometrial function and labor, which may help further the understanding of abnormal uterine function in the clinical setting. Significance Preterm birth affects 10 to 12% of all pregnancies and is the primary cause of neonatal morbidity and mortality worldwide, while prolonged labor increases the risks of infection, uterine rupture, and neonatal distress. Progesterone suppresses uterine contractions. As humans maintain high levels of progesterone throughout parturition, a “functional progesterone withdrawal” hypothesis suggests that switching between myometrial PGR-A and PGR-B isoform activities is crucial for transitioning into the parturition mode. Our mouse models provide evidence in support of this hypothesis. These findings also demonstrate a significant difference in downstream transcriptomic landscapes between the two PGR isoforms. Therefore, this work opens a venue to investigate the PGR isoform interacting signaling for parturition control, providing a possible pathway for developing clinical therapies.

1 August 2014 in Endocrinology
Verified
Journal Article
Open access
PDF file
Chellakkan Selvanesan BlessonChellakkan Selvanesan Blesson
Chellakkan Selvanesan Blesson
KSKunju Sathishkumar
Kunju Sathishkumar
VCVijayakumar Chinnathambi
Vijayakumar Chinnathambi
CYChandrasekhar Yallampalli
Chandrasekhar Yallampalli
Type II diabetes originates from various genetic and environmental factors. Recent studies showed that an adverse uterine environment such as that caused by a gestational low-protein (LP) diet can cause insulin resistance in adult offspring. The mechanism of insulin resistance induced by gestational protein restriction is not clearly understood. Our aim was to investigate the role of insulin signaling molecules in gastrocnemius muscles of gestational LP diet–exposed male offspring to understand their role in LP-induced insulin resistance. Pregnant Wistar rats were fed a control (20% protein) or isocaloric LP (6%) diet from gestational day 4 until delivery and a normal diet after weaning. Only male offspring were used in this study. Glucose and insulin responses were assessed after a glucose tolerance test. mRNA and protein levels of molecules involved in insulin signaling were assessed at 4 months in gastrocnemius muscles. Muscles were incubated ex vivo with insulin to evaluate insulin-induced phosphorylation of insulin receptor (IR), Insulin receptor substrate-1, Akt, and AS160. LP diet-fed rats gained less weight than controls during pregnancy. Male pups from LP diet–fed mothers were smaller but exhibited catch-up growth. Plasma glucose and insulin levels were elevated in LP offspring when subjected to a glucose tolerance test; however, fasting levels were comparable. LP offspring showed increased expression of IR and AS160 in gastrocnemius muscles. Ex vivo treatment of muscles with insulin showed increased phosphorylation of IR (Tyr972) in controls, but LP rats showed higher basal phosphorylation. Phosphorylation of Insulin receptor substrate-1 (Tyr608, Tyr895, Ser307, and Ser318) and AS160 (Thr642) were defective in LP offspring. Further, glucose transporter type 4 translocation in LP offspring was also impaired. A gestational LP diet leads to insulin resistance in adult offspring by a mechanism involving inefficient insulin-induced IR, Insulin receptor substrate-1, and AS160 phosphorylation and impaired glucose transporter type 4 translocation.

7 June 2014
Verified
Book Chapter
Closed access
PDF file
CYChandrasekhar Yallampalli
Chandrasekhar Yallampalli
MCMadhu Chauhan
Madhu Chauhan
JEJanice Endsley
Janice Endsley
KSKunju Sathishkumar
Kunju Sathishkumar

1 November 2015 in Placenta
Verified
Journal Article
Closed access
ABAndrey Bednov
Andrey Bednov
JEJimmy Espinoza
Jimmy Espinoza
ABAncizar Betancourt
Ancizar Betancourt
YVYuri Vedernikov
Yuri Vedernikov
MBMichael Belfort
Michael Belfort
CYChandrasekhar Yallampalli
Chandrasekhar Yallampalli

17 July 2018 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
YDYuanlin Dong
Yuanlin Dong
MCMadhu Chauhan
Madhu Chauhan
ABAncizar Betancourt
Ancizar Betancourt
MBMichael Belfort
Michael Belfort
CYChandrasekhar Yallampalli
Chandrasekhar Yallampalli
Context Impaired maternal lipid metabolism in gestational diabetes mellitus (GDM) has detrimental effects on maternal health and fetal growth. We have previously reported excessive expression of adrenomedullin (ADM) and its receptors in GDM adipose tissues when compared with normal glucose tolerant pregnancies. In this study we determine the mechanisms underlying enhanced ADM and its receptors expressions. Design Omental adipose tissues (OAT) were collected from women during caesarian sections in term pregnancy with non-overweight (NOW, n=9), overweight (OW, n=8), obese (OBS, n=10), and GDM (n=10). Results ADM and its receptors were higher in OAT from GDM compared with NOW, OW, and OBS women. The expression of adipokines, leptin and resistin, were significantly increased, but adiponectin was decreased in OAT from GDM compared with non-GDM patients. Macrophage infiltration and TNF-α expression were greater in OAT from pregnant women with GDM compared to non-GDM patients. Further, TNF-α dose-dependently increased mRNA for ADM and its receptor components CRLR, RAMP2, and RAMP3 in OAT explants from NOW women. Human adipocytes treated with ADM significantly increased glycerol release in culture medium, and the increases of glycerol in culture medium of OAT from GDM women were attenuated by ADM antagonists, ADM22-52. Conclusions Increased macrophage infiltration and TNF-α expression in in adipose tissue from GDM, but not from OBS, stimulate ADM and its receptor overexpression, leading to enhanced lipolysis and hyperlipidemia, thus may contribute to fetal macrosomia and adiposity in diabetic pregnancies.